Evidence map›Paper›PMID 18351461›Full record

ArticleNeurochemical research2008

Overexpression of Cdk5 or non-phosphorylatable retinoblastoma protein protects septal neurons from oxygen-glucose deprivation.

Kiran S Panickar, Doris Nonner, Michael G White, John N Barrett

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kiran S PanickarDepartment of Physiology & Biophysics, University of Miami Miller School of Medicine, Miami, FL 33101, USA. kiran.panickar@ars.usda.gov
Doris Nonner
Michael G White
John N Barrett
University of Miami · USBeltsville Human Nutrition Research Center · US

Funding

NEUROTROPHIN PROTECTION OF STRESSED CHOLINERGIC NEURONSR01NS012207 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BARRETT, JOHN N · 1985 to 2003
$1.3M
NINDS NIH HHS NS 12207
6 · The paper itself

Abstract

Activation of cyclin dependent kinases (Cdks) contributes to neuronal death following ischemia. We used oxygen-glucose deprivation (OGD) in septal neuronal cultures to test for possible roles of cell cycle proteins in neuronal survival. Increased cdc2-immunoreactive neurons were observed at 24 h after the end of 5 h OGD. Green fluorescent protein (GFP) or GFP along with a wild type or dominant negative form of the retinoblastoma protein (Rb), or cyclin-dependent kinase5 (Cdk5), were overexpressed using plasmid constructs. Following OGD, when compared to controls, neurons expressing both GFP and dominant negative Rb, RbDeltaK11, showed significantly less damage using microscopy imaging. Overexpression of Rb-wt did not affect survival. Surprisingly, overexpression of Cdk5-wild type significantly protected neurons from process disintegration but Cdk5T33, a dominant negative Cdk5, gave little or no protection. Thus phosphorylation of the cell cycle regulator, Rb, contributes to death in OGD in septal neurons but Cdk5 can have a protective role.

Indexed as

AnimalsCDC2 Protein KinaseCell CycleCyclin-Dependent Kinase 5GlucoseNeuronsOxygenRatsRats, Sprague-DawleyRecombinant Fusion ProteinsRetinoblastoma ProteinSeptum of BrainCDC2 Protein KinaseCyclin-Dependent Kinase 5GlucoseOxygenRecombinant Fusion ProteinsRetinoblastoma Protein

Identifiers

PMID18351461
OpenAlexW2169396519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.